The fight over whether EPA should keep allowing paraquat to be sprayed on U.S. fields continued with dueling comments submitted to EPA on its recent reconsideration of a wide range of issues involving the controversial herbicide.
By Healthcare Edge Editorial Staff Octave Bioscience, Inc., a company offering treatment for multiple sclerosis and other neurodegenerative diseases, said it has received a $10 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The company stated it will utilize the funds for research, development, and validation of a custom […]